JPRN-UMIN000027633
Recruiting
未知
Randomized phase II study of neoadjuvant chemoradiotherapy (S-1+radiation) for resectable pancreatic cancer with less than 180 degree portal vein abutment - Randomized phase II study of neoadjuvant chemoradiotherapy (S-1+radiation) for resectable pancreatic cancer with less than 180 degree portal vein abutment
agoya University, Graduate School of Medicine0 sites56 target enrollmentJuly 1, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- resectable pancreatic cancer with less than 180 degree portal vein abutment
- Sponsor
- agoya University, Graduate School of Medicine
- Enrollment
- 56
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Patients who have allergies to S\-1 (2\) Patients who have active infection (3\) Patients with active peptic ulcer (4\) Patients with ileus (5\) Patients with Grade\>\=2 diarrhea according to CTCAE v4\.0 (6\) Patients with uncontrolled ascites or pleural effusion (7\) Patients with flucytosine, phenytoin, or warfarin potassium administration (8\) Patients with serious comorbid conditions (9\) Patients with pregnancy (10\) Patients with serious psychiatric diseases (11\) Patients who were deemed inappropriate for medical reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Bintrafusp alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma.retroperitoneal sarcomasMedDRA version: 20.0Level: LLTClassification code 10039494Term: Sarcoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10077289Term: Retroperitoneal sarcomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2021-001085-37-FRInstitut Bergonié66
Completed
Not Applicable
Randomized phase II study of neoadjuvant chemotherapy with or without letrozole for postmenopausal ER-positive/HER2-negative breast cancersPostmenopausal breast cancerJPRN-UMIN000008416Kobe Breast Cancer Oncology Group70
Active, not recruiting
Phase 1
Study of chemotherapy and immunotherapy for patients with lung cancer bounded in the thorax and potentially resectableon-small cell lung cancerMedDRA version: 20.0 Level: LLT Classification code 10029514 Term: Non-small cell lung cancer NOS System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-004515-45-ESFundación GECP90
Active, not recruiting
Phase 1
Study of chemotherapy and immunotherapy for patients with lung cancer bounded in the thorax and potentially resectableon-small cell lung cancer (NSCLC)MedDRA version: 21.1Level: LLTClassification code: 10029514Term: Non-small cell lung cancer NOS Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]CTIS2024-513731-24-00Fundacion GECP90
Completed
Phase 2
Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2Breast CancerJPRN-UMIN000000651Office for cordination of Herceptin trial100